Hilar Lymphadenectomy Is Associated With Improved Disease‐Free Survival in Pathologically N0 Non‐Small Cell Lung Cancer

Documenti analoghi

• BRCA1‐associated protein 1 : Tumor predisposition syndrome and Kury‐Isidor syndrome, from genotype–phenotype correlation to clinical management
  di: Elizabeth Casey West, et al.
  Pubblicazione: (2024)
• Survival Analysis of Postoperative Adjuvant Chemotherapy for Stage IB Non‐Small Cell Lung Cancer Based on Racial Stratification
  di: Shaowei Xin, et al.
  Pubblicazione: (2025)
• Preoperative Computed Tomography Colonography‐Angiography for Vascular Mapping to Guide and Standardize D3 Lymphadenectomy in Right‐Sided and Transverse Colon Cancer
  di: Takeharu Kato, et al.
  Pubblicazione: (2026)
• Optimising Robotic Radical Gastrectomy: A Technical Roadmap for Bipolar Forceps‐Assisted Lymphadenectomy and Reconstruction
  di: Fengyuan Li, et al.
  Pubblicazione: (2026)
• Comparison of Survival Outcomes of Early‐Stage Non‐Small‐Cell Lung Cancer in Elderly Patients (≥ 70 years) Treated With Stereotactic Body Radiotherapy Versus Surgical Resection
  di: Guo‐jun Wu, et al.
  Pubblicazione: (2025)